RNA-ChIP with MALAT1 (Fig. 2b) revealed a differential response: interaction between MALAT1 and ERβ in PCa cells and or between MALAT1 and ERα in breast cancer cells, both detectable in basal condition, was not affected by E2 treatment. The gene discussed is ESR1; the disease is breast carcinoma.